Molecular imaging of gene therapy for cancer.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1175, doi. 10.1038/sj.gt.3302278
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2004 AND VI 11 AND IP 15
Results: 7
1
2
Tumor-specific gene expression using the survivin promoter is further increased by hypoxia.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1215, doi. 10.1038/sj.gt.3302280
- By:
- Publication type:
- Article
3
Potential therapeutic applications of recombinant, invasive E. coli.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1224, doi. 10.1038/sj.gt.3302281
- By:
- Publication type:
- Article
4
Transgenic rescue of Krabbe disease in the twitcher mouse.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1188, doi. 10.1038/sj.gt.3302282
- By:
- Publication type:
- Article
5
Infectious delivery of the 132?kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1195, doi. 10.1038/sj.gt.3302284
- By:
- Publication type:
- Article
6
Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1205, doi. 10.1038/sj.gt.3302285
- By:
- Publication type:
- Article
7
Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor.
- Published in:
- Gene Therapy, 2004, v. 11, n. 15, p. 1234, doi. 10.1038/sj.gt.3302286
- By:
- Publication type:
- Article